top of page
Blog


Navigating FDA and EU Guidelines for Documenting Design Changes Efficiently
In today's landscape of medical device development, regulatory compliance is essential. Efficiently documenting design changes is crucial...
Jul 15, 2025


Building a Global Regulatory Strategy to Avoid Costly Redesigns and Delays
In the fast-paced world of international business, navigating global regulations is crucial for success.
Jul 10, 2025


Identifying and Addressing Technical File Gaps to Prevent Audit Findings
In today's tightly regulated landscape, the need for thorough technical files cannot be underestimated.
Jul 8, 2025


Navigating EU MDR Post-Market Surveillance Common Mistakes and Current Challenges
In the fast-changing world of medical device regulation, the European Union Medical Device Regulation (EU MDR) has set strict requirements for post-market surveillance (PMS).
Jul 2, 2025


Navigating Leadership Transitions in RAQA Projects
Understanding the Impact of Leadership Turnover Leadership changes can create instability within a team, particularly in the complex...
Jun 27, 2025


Navigating FDA 483 Observations: Key Insights for 2025
Understanding FDA 483 Observations Form 483 is given by FDA inspectors when they see conditions in a facility that may violate FDA...
Jun 20, 2025


Is Your Technical File Prepared for MDR Compliance Checks Before the Next Audit
Introduction As EU medical device regulations evolve, companies must remain vigilant in ensuring their technical documentation aligns...
Jun 18, 2025


Navigating FDA Remote Regulatory Assessments: Essential Preparation Strategies for Life Science Companies
In the wake of the ever-evolving regulatory landscape, life science companies must be attentive to the various pathways that the FDA...
Jun 17, 2025


How Proper Risk Planning Can Protect Your Business
In today’s dynamic business landscape, uncertainty is a constant challenge. Every business, regardless of size or industry, faces a...
Jun 16, 2025


Understanding the FDA's Draft Guidance on 510(k) Transfer of Premarket Notification and Key Recommendations
The Food and Drug Administration (FDA) has recently released a draft guidance document aimed at the healthcare and medical device...
Jun 10, 2025


Understanding the Critical Role of Clinical Evaluation in Medical Device Approval Processes
The world of medical devices is rapidly evolving, bringing about remarkable advancements in how we diagnose, treat, and manage patient...
Jun 6, 2025


Essential Best Practices for Effective Post-Market Surveillance in Medical Device Companies
Post-market surveillance (PMS) is crucial for the ongoing safety and effectiveness of medical devices after they hit the market. As...
Jun 6, 2025


Inside the FDA’s AI Shift: What Life Sciences Leaders Need to Know About Elsa
On June 4, 2025, the U.S. Food and Drug Administration (FDA) announced the launch of Elsa , a new generative artificial intelligence (AI)...
Jun 4, 2025


Decoding the New UKCA Mark: Essential Insights for Medical Device Companies
In the wake of Brexit, the United Kingdom has created its own set of rules for different industries, including medical devices. The UK...
May 29, 2025


Navigating the Future of FDA 510k Submissions Through eSTAR Insights and Implications for Regulatory Leaders
n the fast-paced world of medical device regulation, keeping up with changes is crucial. One of the most significant shifts is the FDA's introduction of the electronic Submission Template and Resource (eSTAR) for 510(k) submissions. This move aims to make the submission process smoother, increase clarity, and ultimately improve patient access to safe medical devices.
For regulatory operations and quality leaders in medical device companies, understanding eSTAR's details i
May 23, 2025


Navigating Common Pitfalls of EU MDR and How to Avoid them in 2025
The European Medical Device Regulation (EU MDR) continues to pose challenges for medical device manufacturers as they strive for compliance.
Apr 14, 2025


Which QMS Certification is Right for Your Company?
For medical device companies, compliance with international quality standards is essential to ensure product safety, regulatory approval, and market access.
Mar 16, 2025


Navigating the FDA's Latest Guidance on AI/ML in Medical Devices
Artificial Intelligence (AI) and Machine Learning (ML) are revolutionizing the medical device industry by enabling adaptive, data-driven...
Mar 16, 2025


FDA’s Perspective on AI in Drug and Biological Product Development
Artificial Intelligence (AI) is rapidly transforming the pharmaceutical and biotechnology industries, offering powerful tools to accelerate drug discovery, enhance clinical trial efficiency, and optimize regulatory decision-making.
Mar 10, 2025


Avoiding FDA Inspection Findings: A Guide for Pharmaceutical and Biotech Companies
The pharmaceutical and biotech industries operate under intense regulatory scrutiny, with the U.S. Food and Drug Administration (FDA) ensuring compliance with Current Good Manufacturing Practices (cGMPs) and other regulatory requirements...
Feb 10, 2025
bottom of page
